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Abstract: Reduced glycolytic and mitochondrial respiration rates are common features 
of apoptosis that may reflect key events contributing to cell death. However, it is unclear 
to what extent the rate changes can be explained by direct alterations in the kinetics of the 
participating reactions, as changes in the concentrations of intermediates also affect 
reaction rates. Direct kinetic changes can be identified, ranked, and compared to the 
indirect effects mediated by the intermediates using top-down control analysis. Flux 
changes that are explained primarily by direct effects are likely to be prime targets of the 
pathways that signal death, and thus important contributors to apoptosis. Control analysis 
concepts relevant to identifying such effects are reviewed. Metabolic flux measurements 
are essential for this approach, but can be technically difficult, particularly when using 
adherent cells such as neurons. A simple method is described that renders such 
measurements feasible. 
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1. Introduction 
 
For newly differentiated neurons to survive during development, the mitochondrial apoptotic 
pathway, a default death program characterized by nuclear condensation, DNA fragmentation, and 
membrane blebbing, must be suppressed [1,2]. This suppression is primarily dictated by trophic factors 
external to the neuron- excitatory neurotransmitters, such as glutamate, and growth factors such as 
insulin-like growth factor-1 and brain-derived neurotrophic factor [3-5]. Trophic factors act to affect 
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the levels/activities of pro- and anti-apoptotic proteins such as Bax, Apaf-1, and IAPs [6,7], and 
possibly, as discussed in this article, the activities of enzymes involved in the uptake and processing of 
glucose. Neurons that survive to become a functional part of the mature nervous system can die 
inappropriately due to a variety of factors that may overcome this suppression. Inappropriate apoptosis 
likely contributes to pathologies such as neurodegenerative diseases [3,8,9] and delayed neuronal 
death in the hours following stroke [10,11]. In some cases, conditions that promote neurodegeneration 
act by inhibiting one or more reactions involved in energy metabolism (i.e., those responsible for 
producing ATP). Oxidative stress, a condition commonly associated with apoptosis and 
neurodegeneration, negatively impacts mitochondrial function. Diminished glutathione levels, a 
manifestation of oxidative stress, inhibits mitochondrial ATP export [12] and complex I activity [13]. 
Complex I defects may be particularly important to development of Parkinson’s disease [13]. 
Mitochondrial accumulation of α-synuclein, implicated in familial Parkinson’s, may also impair 
complex I [14]. Complex I restriction by chronic, low-dose rotenone administration induces 
Parkinson’s-like symptoms in rats [15]. Aggregated β amyloid protein and tau, the hallmarks of 
Alzheimer’s disease, may infiltrate membranes to potentially affect glucose transport and 
mitochondrial function [16-20]. In Huntington’s disease, mutant huntingtin protein may also impair 
mitochondrial function [21-23]. These effects may promote apoptosis by facilitating mitochondrial 
cytochrome c release. While such instances of direct metabolic inhibition have been identified in 
pathologies associated with inappropriate apoptosis, it is unclear if physiological apoptotic triggers act 
in the same way.  
Reduced glycolytic and mitochondrial fluxes are common features of physiological apoptosis 
induced by limited trophic factor support, yet the basis for the change in flux is uncertain. Growth 
factor restriction is associated with reduced glycolytic flux in non-neuronal cells, possibly due to 
inhibition of one or more glycolytic steps [24-28]. Glutamate stimulates cerebellar granule neuron 
respiration [29-31], implying that limited availability reduces metabolism. While these observations 
are consistent with metabolism contributing to physiological apoptosis, the underlying processes that 
bring about a flux change have not been comprehensively considered. Growth factor deprivation may 
alter the kinetics of a particular reaction, but the consequences of this on the rate at which a pathway 
operates (i.e., its flux) is often difficult to ascertain. Stated another way, where a change in flux has 
been observed, the extent to which it can be attributed to a particular reaction is often unclear. 
Metabolic control analysis has shown that the flux through most pathways is controlled by a number of 
steps such that a change in activity of one reaction often has small effects on the overall rate [32]. 
Metabolic flux varies in most cells primarily because of variations in ATP demand which, as described 
later, indirectly affect reaction rates through changes in the concentrations of the intermediates in the 
pathway. A flux change brought about in this way is arguably unimportant for signaling apoptosis, yet 
such changes are usually not considered. The goal of this article is to review the utility of top-down 
control analysis [33] as an approach to identifying and ranking both direct kinetic and indirect 
intermediate changes responsible for perturbing a steady-state. This approach considers blocks of 
enzymes as a single reaction, thereby simplifying cellular complexity to an experimentally workable 
system. The analysis quantifies how the blocks respond to a select group of intermediates, and the 
control the blocks have in establishing a steady-state. This information can then be used to assess the 
different routes through which an apoptotic stimulus brings about a change in steady-state flux. Int. J. Mol. Sci. 2009, 10                 
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Cerebellar granule neurons are introduced as a model system in which to study apoptosis. This is 
followed by a review of concepts important to control analysis, and a description of how the concepts 
can be practically applied to neurons. 
 
2. Metabolic changes during cerebellar granule neuron apoptosis 
 
Cerebellar granule neurons (CGNs) isolated from newborn rats mature in vitro when cultured with 
fetal bovine serum as a source of growth factors, and non-physiologically high extracellular K
+ 
(typically 25 mM) to mimic tonic excitatory synaptic input [34-37]. When deprived of these trophic 
factors, CGNs display the classic morphological and biochemical signatures of death by apoptosis- 
nuclear condensation [34,38], DNA laddering [34,39], phosphatidylserine exposure [38], Bax 
activation [6,40], and cytochrome c redistribution [39,41]. High K
+ depolarizes the plasma membrane 
potential (ΔΨp  ≈ -35 mV) [42] sufficiently to open voltage-gated L-type Ca
2+ channels. This 
approximately doubles the cytoplasmic Ca
2+ concentration ([Ca
2+]c) from the low K
+ (i.e., 3-5 mM) 
state, where the majority of L-type Ca
2+ channels are closed (ΔΨp ≈-75 mV) [43-45]. Physiologically, 
glutamate is the prime determinant of plasma membrane Ca
2+ permeability, but is impractical to use in 
vitro because it is metabolized and can additionally induce death with extended exposure at moderate 
concentrations. Thus, in vitro neurons exposed to low K
+ can be viewed as similar to those in vivo that 
fail to establish active excitatory synaptic contacts.  
The change in [Ca
2+]c from high to low K
+ significantly affects CGN metabolism [38]. Specifically, 
mitochondrial oxidative phosphorylation rate falls 40%, and glycolytic ATP synthesis rate decreases 
approximately 20% [38]. The changes are dependent on the [Ca
2+]c, as the effect can be reproduced by 
omitting Ca
2+ from high K
+ buffer [38], a condition that lowers [Ca
2+]c to a level similar to that in low 
K
+. Lower [Ca
2+]c could affect metabolism in two ways. First, the kinetics of the enzymes may be 
affected, either by Ca
2+ directly (e.g., activation of tricarboxylic acid cycle dehydrogenases and thus 
pyruvate oxidation with Ca
2+ uptake into the matrix), or by the phosphorylation state of the enzymes or 
regulatory proteins that affect them, because of altered Ca
2+-dependent kinase (e.g. calcium-
calmodulin-dependent and mitogen activated protein kinases) activity. Second, ATP demand may 
decline as a result of decreased plasma membrane Ca
2+ cycling which, as described below, will alter 
enzyme activity through changes in the concentrations of intermediates. It is unclear to what extent 
each might contribute to the changes in glycolytic and oxidative phosphorylation fluxes.  
Superimposed on the Ca
2+-dependent changes are those mediated by growth factor deprivation, 
which acts synergistically with low K
+ to facilitate CGN apoptosis [41,46,47]. Physiologically, this 
may occur as the expanded neuron population competes for a limited pool of growth factors [3,4,48-
50]. Activation of receptor tyrosine kinases (RTKs) by growth factors has been shown to stimulate 
TRP channels [51], thereby potentially contributing to the Ca
2+-dependent mechanisms. More 
importantly, RTKs stimulate a number of survival kinase pathways, the most important of which in 
many cells is phosphatidylinositol-3-kinase (PI-3K) and its downstream target protein kinase B/Akt. 
The PI-3K/Akt pathway may target steps in glycolysis, potentially explaining the flux changes 
observed during apoptosis [24,52]. Interleukin withdrawal induces apoptosis and suppresses glycolytic 
flux in hematopoietic cells [26,27]. Insulin-like growth factor-1, which can rescue CGNs and other 
primary neuronal cultures from apoptosis through PI-3K/Akt [47], stimulates glycolytic flux in a Int. J. Mol. Sci. 2009, 10                 
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neuronal cell line [28]. Inhibition of hexokinase/glucokinase [28,52-55], phosphofructokinase [26] and 
glucose transport [27,52,56] has been suggested to explain the suppression of glycolysis observed 
upon growth factor withdrawal. The phosphorylation state of the pro-apoptotic protein BAD may be 
one of the links between apoptosis and metabolism, as it has been shown to interact with hexokinase 
[55] and phosphofructokinase [26] in a growth factor-dependent manner.  
The emergence of glycolytic suppression as a potential contributor to apoptosis complements 
studies showing abnormally high flux rates in cancer cells, many of which are resistant to apoptosis. 
However, it is crucial to know the extent to which the decreased flux observed during apoptosis can be 
attributed to changes in (1) the kinetics of the glycolytic reactions and (2) the concentrations of 
intermediates to which the glycolytic enzymes respond. If the flux decreases primarily because of 
altered reaction kinetics, then this could have important consequences on mitochondrial function and 
ATP levels, whereas if it decreases due to changes in the concentrations of key intermediates, then the 
apoptotic signaling must be acting elsewhere in the system. In this respect, it is important to view 
glycolysis as a reaction embedded within a larger pathway (whose principle function is to produce 
ATP) so that potential signaling routes that do not target glycolysis but nonetheless affect its flux can 
be considered. By broadening the scope of metabolism to include those reactions connected to 
glycolysis through key intermediates, a more comprehensive picture of the actions of apoptosis will  
be achieved.  
Glycolytic flux is strongly affected by ATP levels, which simultaneously affect the rates of multiple 
reactions. The balance of rates of ATP utilization and production establishes the ATP level. Most 
studies have not determined the extent to which ATP utilization changes with apoptosis, and, if so, 
how much the change can explain the suppression of glycolysis through effects on ATP levels. 
Granule neurons are a good example, where decreased Ca
2+ cycling and subsequent decreased ATP 
utilization may explain much of the decrease in glycolysis. Increased ATP could also occur by 
activation of the mitochondrial phosphorylation reactions. Thus, the processes altering glycolytic flux 
could be through direct actions on the glycolytic enzymes, or signaling that acts elsewhere to influence 
key metabolites, or a combination of these.  
Assume that at least some of the decrease in glycolysis can be explained by direct inhibition of one 
or more glycolytic reactions. It would be useful to know how much this affects mitochondrial substrate 
oxidation and ATP synthesis. Glycolytic impairment has been implicated in restricting cellular ATP 
supply, both through reduced substrate level phosphorylation and by restricting mitochondrial 
substrate supply, thereby promoting mitochondrial dysfunction. However, in most cells glycolysis 
accounts for considerably less than half of total ATP synthesis, so decreased glycolysis may have little 
effect on ATP levels. It has been suggested that mitochondrial ATP synthesis decreases because of 
substrate limitation, but this has not been rigorously tested. Much of the glucose that enters glycolysis 
is not oxidized by mitochondria, but ends up exported from the cell as lactate. It can be argued that 
impaired glycolysis results in a greater proportion of pyruvate being oxidized by the mitochondria 
rather than being converted to lactate, resulting in no diminution in mitochondrial substrate supply 
under physiological conditions. For these reasons, when apoptotic stimuli directly affect glycolysis, it 
is important to assess the extent to which this functionally alters mitochondrial substrate oxidation 
and/or phosphorylation. A systems biology approach to metabolism, through the use to top-down 
control analysis, can help resolve some of these uncertainties. Int. J. Mol. Sci. 2009, 10                 
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Direct changes in the kinetics of those reactions which together exert significant control over a 
pathway flux indicate a concerted action that is likely important to apoptosis. Despite extensive 
analysis of the early bioenergetic changes occurring in K
+/serum deprived CGNs, direct kinetic 
changes and indirect effects mediated through the intermediates were not distinguished [38]. As 
mentioned above, one primary disturbance elicited by K
+/serum deprivation is decreased Ca
2+ cycling 
and hence decreased ATP utilization.  This primary disturbance is propagated throughout other 
reactions within the metabolic network through changes in the concentrations of other key 
intermediates in the system. Reduced ATP utilization produces a transient imbalance in supply and 
demand: ATP synthesis rate by glycolysis and the mitochondrial phosphorylating system exceeds 
utilization, resulting in increased ATP/ADP ratio. Consistent with this scheme, higher ATP levels have 
been measured after K
+/serum deprivation [57]. This will inhibit glycolytic and phosphorylating 
system fluxes through effects on enzymes such as pyruvate kinase and ATP synthase whose activities 
are affected by ATP levels. As these fluxes decrease, other transient imbalances occur, and the initial 
disturbance begins to propagate through the system. 
Looking one step further in this scheme, reduced glycolytic flux will increase glucose-6-phosphate 
levels as its rate of production by glucose uptake and phosphorylation reactions exceeds the now lower 
consumption through glycolysis. The increased concentration of glucose-6-phosphate negatively 
affects hexokinase and thus the rate of glucose phosphorylation. At the same time, decreased 
mitochondrial phosphorylation system flux causes transient inequity between production and 
consumption of the mitochondrial protonmotive force. Proton extrusion by the respiratory chain 
exceeds influx through the now slightly less active ATP synthase. The protonmotive force increases, 
resulting in inhibition of the oxidation reactions that produce it.  
This series of events illustrates how a direct change in flux through one group of reactions (those 
that utilize ATP) due to a primary disturbance (such as decrease cytoplasmic Ca
2+) begins a series of 
transient inequalities in reaction fluxes that produce and consume intermediates within the energy 
metabolism pathway. This produces changes in the concentrations of the intermediates connecting 
them, which then alter the reaction rates of the enzymes. Thus, the initial disturbance propagates 
throughout the metabolic network until a new steady-state is achieved. Flux changes arising from these 
indirect changes in the concentrations of key intermediates are probably not important in signaling 
apoptosis, as these would be changes that occur in the normal course of metabolism of any healthy 
cell. This description, however, is a qualitative one, where it has been assumed that once a primary 
disturbance occurs, any flux change elsewhere arises entirely as a result of the changes in the 
concentrations of intermediates. It is possible that one or more reactions are affected to a greater (or 
lesser) extent than would be expected simply by the changes in intermediate concentrations. A number 
of kinases, phosphatases, and/or pro-apoptotic proteins affected by K
+ /serum deprivation could 
mediate these effects. Such direct changes would be candidate signaling steps contributing to 
apoptosis, but they would be obscured because of the indirect changes that may also occur. Regulation 
analysis is a branch of metabolic control analysis that can be used to distinguish between primary and 
secondary changes, and additionally provide quantitative information on how strongly different 
reactions are directly affected [58]. Such an approach, when applied to whole cells using a ‘top-down’ 
view, would provide a comprehensive description of the sites targeted by apoptotic stimuli. 
 Int. J. Mol. Sci. 2009, 10                 
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3. Top-down metabolic control analysis 
 
Cells are inherently steady-state systems, meaning that the rate of any given metabolic pathway 
does not continuously fluctuate with time, but rather tends to remain constant. As an electrical 
analogy, cells can be viewed as direct current rather than alternating current systems. The steady-state 
can, and does, vary depending on prevailing physiological conditions (e.g., the presence of a hormone, 
the workload of the cell, etc.). Control analysis was developed to quantitatively describe the 
contribution of each reaction to bringing about small variations in the steady-state flux through any 
given point in a pathway [59-61]. It is based on the ‘connectedness’ of multiple reactions through the 
shared intermediates. In a simple 2-step pathway, an enzyme E1 can exert control over the flux 
catalyzed by a second enzyme E2 through its effects on influencing the concentration of the 
intermediate to which E2 responds. As shown below, the intermediate x produced by E1 is the substrate 
for E2. 
 
For simplicity, assume an infinite source of substrate S and infinite sink of product P such that 
their concentrations do not change with time; since their effects on E1 and E2 are constant, any change 
in the reaction rates can be attributed to changes in the concentration of intermediate x. Prior to 
reaching a steady-state, as E1 produces x, its concentration will increase such that (1) E2 consumes x at 
an increasing rate as its concentration approaches the E2 Michaelis constant, and (2) E1 produces x 
more slowly because of product inhibition. The rates ultimately converge to establish a steady-state 
flux, with the kinetics of both enzymes to x determining when this is achieved. Since the kinetics of E1 
to x partly determines the steady-state concentration of x, which in turn influences the rate of E2, then 
E1 will exert control over the reaction catalyzed by E2. The flux control coefficient is a measure of this 
control and is defined as: 
1 1
2 2
/
/
2
1
E E
E E E
E v dv
J dJ
C =        ( 1 )  
where  2 E dJ   is the flux change through E2 as a result of an infinitesimal change  1 E dv   in the rate 
through E1. The E1 rate change is denoted v to indicate that its rate has been directly manipulated (for 
example, by changing the amount of active enzyme or by addition of an inhibitor or activator); the E2 
rate is denoted  2 E J  to indicate that it is a measured system flux dependent on the concentrations of the 
intermediates in the system. If E1 exerts only partial control over E2 flux (that is, 
1 1 2 2 E E E E v dv J dJ < ), then E2 exerts the remaining control over its own flux, such that  1
2
2
2
1 = +
E
E
E
E C C . 
If E1 and E2 are part of a larger pathway as illustrated below, then the control E1 and E2 exert over E2 
flux will also depend on how the remaining enzyme(s) affect the concentrations of pathway 
intermediates to which E2 responds.  
 
In this example, the product of the reaction catalyzed by E2- intermediate y- is the substrate for a 
third reaction catalyzed by enzyme E3. Assuming y exerts inhibition on E2, the kinetics of E3 to y will 
partly determine the concentration of y, and thus the flux through E2. Enzyme E3 will therefore exert 
some degree of control over E2 through its effects on establishing the concentration of y, and in so Int. J. Mol. Sci. 2009, 10                 
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doing lessens some of the control by E1. The concentration of x is no longer the only influence on E2; 
the product y is now explicitly considered as also affecting E2. As the pool of intermediates that 
influence a reaction flux increases, so too will the number of reactions involved in controlling the flux 
because of their effects on determining the concentrations of the intermediates. If, in one particular 
steady-state, a reaction has more influence on dictating the concentrations of intermediates than in 
another steady-state, then it will exert more control in the former state, while the remaining enzymes 
collectively exert less control. Flux control coefficients are therefore properties of the system operating 
at a given steady-state and are unique to that state.  
From this example, it is apparent that multiple reactions in a pathway have the potential to control 
the flux through a reaction of interest in the same pathway because of their effects in determining the 
concentrations of the intermediates. Quantifying the kinetics of the reactions to the intermediates is 
central to control analysis, as the balance of these responses determines the control pattern that 
emerges in a steady-state. In control analysis, the responsiveness of an enzyme to an intermediate is 
given by the elasticity coefficient: 
x dx
v dv E E E
x /
/ 2 2 2 = ε        ( 2 )  
where  2 E dv  is the rate change through enzyme E2 as a result of an infinitesimal change dx in the 
concentration of intermediate x. Here the rate of the reaction catalyzed by E2 is designated v rather 
than J  to emphasize that elasticities denote how the reaction rate of an isolated enzyme is affected by 
a small concentration change in one intermediate while all other intermediates are held constant. For 
elasticities to be applicable to the conditions existing within cells, each must be determined in the 
presence of the physiological concentrations of all other relevant intermediates and effectors. As with 
control coefficients, the elasticities are only valid for the steady-state condition in which they   
are determined. 
Elasticities and flux control coefficients have been determined for limited segments of metabolic 
pathways but not complete ones due to the enormous experimental effort required. However, Ainscow 
and Brand [62] have shown that elasticities and control coefficients can be determined for metabolic 
pathways within cells by reducing the number of explicit steps to be analyzed. This is done by 
grouping multiple enzymes together as a single step or block, with the blocks linked by a few key 
intermediates [63]. Known as the ‘top-down’ approach to control analysis, it provides information on 
the control pattern present within a complex metabolic network operating at a particular steady-state. 
More importantly, the information obtained can be used to determine how a parameter external to the 
system (e.g., the presence of an apoptotic stimulus) brings about a change in system flux through its 
direct effects on the different blocks in the system [64,65]. The direct effects are quantified as 
“integrated elasticities” (see below), which can be used with the flux control coefficients to identify 
the extent to which a flux change through one block (such as glycolysis) occurs indirectly because of 
the parameter acting directly on the other blocks in the pathway [64]. Since this approach both 
identifies sites within a complex pathway that are directly affected by a parameter, and additionally 
provides information on how strongly each affected site contributes to the flux change through the 
other reactions in the system, it has the potential to provide a comprehensive understanding of how 
apoptosis acts to bring about energy metabolism changes. The information will be useful in directing Int. J. Mol. Sci. 2009, 10                 
 
 
709
research efforts toward the enzymes within a particular block which may be targeted by   
apoptosis signaling.  
Energy metabolism can broadly be defined as those reactions involved in the production and 
consumption of ATP. Evidence to date suggests that the glycolytic and/or mitochondrial reactions are 
targeted by apoptosis signaling, so a relatively detailed division of energy metabolism around these 
blocks is required. Figure 1 illustrates one way to do this while keeping the system sufficiently simple 
so that it is experimentally practical.  
 
Figure 1. A simplified model of energy metabolism. Reactions involved in producing and 
consuming ATP have been grouped into 10 blocks separated by 6 intermediates. The 
blocks are numbered as (1) glucose transport and phosphorylation (GTP), (2) glycolysis 
(GLY), (3) pyruvate oxidation (PYR), (4), NADH oxidation (NAO), (5) lactate production 
(LAC), (6) mitochondrial phosphorylating system (PHO), (7) mitochondrial H
+ leak 
(PRL), (8) ATP consumers (ATC), (9) pentose phosphate pathway (PPP), and (10) 
NADPH oxidation (NPO). G6P: glucose-6-phosphate; ΔΨm: mitochondrial   
membrane potential. 
 
 
The blocks are based on those conceived by Ainscow and Brand to investigate the control of 
hepatocyte energy metabolism [62], with a few modifications. First, unlike hepatocytes, neurons do 
not store appreciable amounts of glycogen, nor do they release glucose, so the current model contains 
a glucose transport and phosphorylation (GTP) block rather than glycogen breakdown and glucose 
release blocks. Second, additional blocks comprising the pentose phosphate pathway (PPP) and 
NADPH oxidation reactions (NPO) have been included to account for the possibility that glucose Int. J. Mol. Sci. 2009, 10                 
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diversion through the PPP exerts control over the blocks directly involved in producing ATP. For the 
analysis to be valid, it is assumed that the blocks communicate only through the explicit intermediates 
connecting them. That is, the control that one block exerts over flux through a second block only 
occurs through effects it has on the concentrations of the explicit intermediates. For example, the 
control PHO may have over GLY flux would occur only through the influence PHO has on 
establishing the concentrations of the explicit intermediates to which GLY has non-zero elasticities. 
Products and substrates external to the outer boundary are assumed to have no affect on system fluxes, 
either because their levels do not change or the changes over the measurement interval do not exert 
effects on the blocks. The thiol redox state may not meet this criterion, as small variations are likely to 
influence NPO flux. However, to keep the system relatively simple, the thiol redox state is not 
explicitly considered; any changes in NPO flux not explained by a change in NADPH/NADP ratio 
(assuming that this is the only non-zero NPO elasticity) could thus be either a direct effect on the NPO 
kinetics, or a change in the thiol redox state. Upon a change in the steady-state, the concentrations of 
the implicit intermediates within the blocks may change, but are assumed to have no influence in 
establishing the flux through another block. The intermediates through which the blocks communicate 
are: (1) glucose-6-phosphate (g6p), the product of the GTP block and substrate for glycolysis (GLY) 
and PPP blocks; (2) pyruvate (pyr), the product of GLY block and substrate for lactate production 
(LAC) and pyruvate oxidation (PYR) blocks; (3) NADH/NAD ratio, product of GLY block and 
substrate for LAC and NADH oxidation (NAO) blocks; (4) mitochondrial membrane potential (ΔΨm), 
product of the PYR and NAO blocks, and substrate for the mitochondrial H
+ leak (PRL) and 
phosphorylating (PHO) blocks; (5) ATP/ADP ratio, product of the GLY and PHO blocks, and 
substrate for the ATP consumer (ATC) block; and (6) NADPH/NADP ratio, product of the PPP block 
and substrate for the NPO block. 
 
4. Determining in situ block elasticities to the intermediates 
 
Within cells, reaction block elasticities cannot be directly determined since it is impossible to vary 
the amount of one intermediate while holding all others constant. They can, however, be calculated 
using a series of modulations designed to perturb the original steady-state. To see this, first consider a 
hypothetical isolated reaction block that responds to an explicit intermediate x. The elasticity of the 
block to x can be estimated by making a finite, small change in x (Δx) and measuring the resulting 
finite fractional change in velocity.  
x x
v v block block block
x Δ
Δ
≈ ε        ( 3 )  
If the block also responds to a second intermediate y, then the process can be repeated by holding x 
constant while making a small finite change in y to obtain 
block
y ε . If small changes in both x and y are 
made simultaneously, then the fractional change in velocity is the sum of the changes induced by x and 
y. By rearrangement of Equation 3, and inclusion of intermediate y, the fractional change is: 
y
y
x
x
v
v block
y
block
x
block
block Δ
⋅ +
Δ
⋅ ≈
Δ
ε ε       ( 4 )  Int. J. Mol. Sci. 2009, 10                 
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Now consider the GLY block in situ, embedded within the complex energy metabolism pathway 
and responsive to at least some of the 6 intermediates. If a finite change in the steady-state has 
occurred due to a change in some physiological parameter that does not directly affect the kinetics of 
the glycolytic enzymes, then the finite fractional change in flux is approximated by: 
NADP NADPH
NADP NADPH
NAD NADH
NAD NADH
ADP ATP
ADP ATP
pyr
pyr
p g
p g
J
J GLY
NADP
NADPH
m
m GLY GLY
NAD
NADH
GLY
ADP
ATP
GLY
pyr
GLY
p g
GLY
GLY
m
Δ
⋅ +
ΔΨ
ΔΨ Δ
⋅ +
Δ
⋅ +
Δ
⋅ +
Δ
⋅ +
Δ
⋅ ≈
Δ
ΔΨ ε ε ε ε ε ε
) (
6
6
6
(5) 
If glycolytic flux and the concentrations of all intermediates are experimentally measured, then the 
elasticities can be solved once five additional equations of the same type are generated. This can be 
done by manipulating different parameters to perturb the original steady-state of healthy neurons in 
different ways. This is known as the multiple modulation approach to determining elasticities [66,67]. 
Each manipulation designed to change the steady-state is referred to as a modulation, and must act at 
defined sites within the system because flux data from a modulation which directly affects a block 
(that is, alters its kinetics from the steady-state being analyzed) cannot be used to determine that 
block’s elasticities. The unknown elasticities are solved by assembling the flux data from modulations 
that do not directly act on that block. Since finite changes in the intermediates must be measured, the 
calculated elasticities are an approximation of the true ones, which reflect infinitesimal changes. 
 
5. In situ targets of apoptotic stimuli: assessing how parameters affect system fluxes 
 
Steady-state systems whose reactions are linked by invariant stoichiometries exhibit matrix 
relations that allow the flux control coefficients to be calculated from the elasticities, fluxes, and 
stoichiometries. Theoretical development of the matrix relations, and their experimental application to 
cells, can be found elsewhere [62,68]. The elasticities and flux control coefficients determined in 
healthy neurons by the multiple modulation technique are the basis for then understanding how a 
parameter change, such as the presence of an apoptotic stimulus, acts to perturb the original steady-
state. A parameter change acting in unknown ways on the system can alter fluxes by the same means a 
modulation can- by directly affecting one or more reaction blocks and by indirectly affecting the 
concentrations of intermediates. Blocks whose kinetics are directly affected will exhibit a flux 
different from that expected purely from a change in the intermediate concentrations. Such blocks can 
be identified, and additionally ranked according to the strength that the parameter change (Δq) exerts 
on the block, by calculating the integrated elasticity (IE ) coefficient [64] as: 
    
i
i block
x
n
i
block
block block
q x
x
J
J
IE
i
Δ
⋅ Σ −
Δ
=
= Δ ε
1       ( 6 )  
where 
block
x ε  are the elasticities determined in healthy neurons, and n=number of intermediates. The 
measured flux change  block block J J Δ , which is known as the integrated response (
block
q IRΔ ), is potentially 
the result of both direct and indirect effects, whereas the summation term (an abbreviated form of 
Equation 5) quantifies only the indirect effects, so the difference represents how strongly a block is 
directly affected. The parameter change should not cause larger changes in the intermediates than 
those measured with the modulations that were used to determine the elasticities. If it does, then there Int. J. Mol. Sci. 2009, 10                 
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will be error in the summation terms, as the true elasticites in the presence of the parameter change 
will likely differ from the ones determined by the modulation method because at least some of the 
block responses to the intermediates will be non-linear.  
The indirect effects imply that the parameter change exerts direct effects on at least one block in the 
system to cause the intermediates to change. Thus, at least one block must have a non-zero integrated 
elasticity to the parameter. The flux change brought about indirectly by each intermediate is referred to 
as the partial integrated response of a block acting through an intermediate, and is given by the 
individual summation terms in Equation 6: 
x
x
IR
block
x
block
q
x Δ
⋅ = Δ ε        ( 7 )    
In summary, a measured fractional flux change 
block
q IRΔ  is quantitatively partitioned into a direct 
component 
block
q IEΔ  and an indirect one 
block
q
x
allx IRΔ Σ , with the indirect component further resolved into 
effects mediated by each intermediate. Where a block (e.g., block 1) is directly affected by the 
parameter change such that  0
1 ≠ Δ
block
q IE , then the effect that has on flux through a second block (block 
2) can be determined as the product of the block 1 flux control coefficient over block 2 (determined in 
healthy neurons) and the integrated elasticity of block 1 to the parameter: 
1 2
1
2 1 block
q
block
block
block
q
block IE C IR Δ Δ ⋅ =        ( 8 )  
This is known as the partial integrated response of a block flux to a parameter change due to the 
direct effect of the parameter on another block. It gives a different perspective from the partial 
integrated response acting through an intermediate (Equation 7) by indicating how a direct change in 
flux through one block affects flux through another because of its actions on changing the 
concentrations of the intermediates (without specifying which intermediates are important). The 
effects exerted by glucagon and epinephrine on hepatocytes illustrate the importance of the partial 
integrated responses in clarifying how a parameter acts to change a flux [65]. Both hormones were 
found to inhibit glycolytic flux; however, glucagon exerted most of its effect through direct inhibition 
of glycolysis, whereas epinephrine primarily acted indirectly through its effect on ATP consumption 
and pyruvate oxidation [65]. These findings emphasize that a measured change in flux must be 
considered within the context of the metabolic pathway in which it is embedded. The integrated 
response is the sum of the effects mediated by all blocks directly affected by a parameter change: 
2
1
2 block
q
blocki
i
r
block
q IR IR Δ = Δ Σ ≈      ( 9 )  
where r is the number of reactions having non-zero integrated elasticities. There may be error in the 
summation terms because the parameter change may affect the control pattern of the system (i.e., the 
flux control coefficients can change), which is determined in healthy neurons. There are indications 
that the control pattern changes are small, as a step-change in Ca
2+ had very small effects on the 
control pattern of isolated skeletal muscle mitochondria despite significant flux changes [69]. If gross 
changes in the control pattern are suspected during application of an apoptotic stimulus, then the 
control coefficients can be re-determined by the multiple modulation approach, which requires 
considerably more time and effort. Consequently, if the control pattern in healthy neurons is used, then 
the partial responses mediated through the different blocks are considered semi-quantitative 
coefficients. In assessing system responses to a parameter change, the term ‘integrated’ in the Int. J. Mol. Sci. 2009, 10                 
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coefficients is to indicate that the values are determined for a single step change in a parameter rather 
than an infinitesimal change, as required for true elasticity and response coefficients.  
For this analysis to be valid, the system studied must maintain a steady-state after the parameter 
change. When the parameter change is a stimulus which induces cell death, is a steady-state possible? 
Granule neurons deprived of K
+ and serum, maintain a constant respiration rate for approximately 3-4 
hr [38]. This is one indication that CGN energy metabolism maintains a steady-state in the early 
phases of apoptosis (i.e., prior to >10% of cells exhibiting morphological changes such as nuclear 
condensation). Another indicator of a steady-state would be the constancy of the intermediate 
concentrations over the time course of the experiments to be run. Experimental application of these 
concepts is not trivial, as it requires measurement of the fluxes through each block as well as the 
concentrations of the intermediates. Standard biochemical assays can be used to determine the 
intermediate concentrations without much difficulty. However, flux measurements can be particularly 
challenging when working with adherent cells such as neurons because of the limitations in 
determining respiration rate, which is crucial for calculating most fluxes. The remainder of this article 
is devoted to a description of a simple method that can be used to measure the rates of respiration, 
glucose utilization, and lactate production in the same preparation of neurons. 
 
6. Flux measurements in neurons: a practical approach 
 
Respiration rate is central to determining fluxes through the blocks which directly produce and 
consume ΔΨm. Most oxygen electrodes require continual stirring to assure uniform oxygen mixing 
between the electrode and the buffer into which it is inserted. With adherent cells, this is problematic 
for two reasons: (1) magnetic stirrers commonly used with oxygen electrodes mix from the chamber 
bottom where attached cells reside, and (2) as a consequence of (1), most commercially available 
chambers are designed for cell suspensions. The problem can be circumvented by scraping or 
trypsinizing cells from their attached substrate, but this is not ideal because of potential damage and 
loss of attachment-mediated signaling. We recently developed a perfusion method that can be used to 
measure the respiration of attached cells [29], but it is not suitable for also determining glucose 
consumption and lactate production so that the fluxes through all reaction blocks can be determined. 
The ideal setup is one where respiration rate, glucose consumption, and lactate production are 
measured in the same cell preparation, as this reduces both the number of cells required and the error 
in calculating the fluxes. A simple setup is described here that fulfills these criteria (Figure 2).  
Granule neurons isolated from rat cerebellum are plated in 2-well Lab-Tek chambers (Nunc), with 
the intent of turning each chamber into a closed system for measuring respiration rate. An acrylic lid 
was custom fabricated to fit tightly into the top of the chamber. It was made with two ports - one to 
hold a conventional micro-oxygen electrode (Microelectrodes, Inc.) and one to make additions. 
Chamber mixing required for proper operation of the oxygen electrode is accomplished with a mini-
neomagnetic stirrer (Instech, Inc.) mounted above the lid to a custom-made removable post that sits in 
an acrylic base. The neo-magnetic is sufficiently strong to control a micro stir bar through the 1cm 
thick lid. The lid with oxygen electrode is assembled into the chamber while holding the micro stir bar 
up against it with the magnet. In this way, the stir bar does not contact the cell layer (Figure 2) and 
mixes the chamber solution from the top rather than bottom. Int. J. Mol. Sci. 2009, 10                 
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Figure 2. Schematic diagram of a batch-mode approach to measuring the respiration rate 
of attached cells.  
 
The setup is kept in a temperature-controlled chamber to record the rates at 37
oC. Because the 
chamber walls are made of oxygen permeable plastic, the rate of oxygen back-diffusion was assessed 
by oxygen-depleting buffer and measuring the increase in oxygen tension over time (Figure 3). To 
date, few experiments have required corrections for back diffusion, as the cells do not usually deplete 
the oxygen by more than 15-20% during a typical 20-50 min measurement period. Where corrections 
have been applied, they are usually less than 5% of the measured respiration rate. 
 
Figure 3. Oxygen back-diffusion rate in 2-well chambers. The cell-free chamber was 
assembled with buffer (150mM NaCl, 20mM TES pH 7.2, 0.3% albumin) partially 
depleted of oxygen with nitrogen. The oxygen tension was measured over 2-3 hours.  
 
Rates were calculated at 5 nmol O/mL intervals. Data are from 5 independent experiments. The 
oxygen concentration in air-saturated buffer at 37
oC was assumed to be 351 nmol O/mL.  
 Int. J. Mol. Sci. 2009, 10                 
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Back-diffusion rates were detectable only when >20% oxygen was depleted. In this configuration, 
neurons in high K
+/serum buffer exhibit respiration rates similar to that measured by the perfusion 
method [29,38], and respond predictably to protonophore (e.g., FCCP) addition, a modulation which 
directly increases flux through the proton leak block (Figure 4).  
 
Figure 4. Representative granule neuron oxygen recording using the 2-well chamber 
system described in Figure 2.  
 
Seven million neurons at 37
oC were incubated in (mM) 116 NaCl, 25 KCl, 20 TES, 10 
glucose, 1.3 CaCl2, 1.3 MgCl2, 1.2 Na2SO4, 0.4 KH2PO4, 0.2 NaHCO3, 10% dialyzed fetal 
bovine serum, pH 7.35. Five to 15 minutes are typically required for a stable baseline to be 
established once assembled. Basal and 1 μM FCCP respiration rates are expressed in nmol 
O/min x 10
6 cells. 
 
The lid can be removed with the stir bar suspended to it so that the cells remain undisturbed for 
measurements of glucose utilization and lactate production. The cells are incubated in a minimal 
volume of buffer over 30-60 min intervals, and the collected samples assayed enzymatically for 
glucose (using hexokinase/glucose-6-phosphate dehydrogenase/NADP, with NADPH detected 
spectrophotometrically) and lactate (using lactate dehydrogenase/glutamate-pyruvate 
transaminase/NAD, with NADH detected fluorimetrically) (Figure 5). Using this approach, it is crucial 
to run parallel control wells without cells to correct for evaporation, which significantly affects the 
concentrations with experiments at 37
oC. With these three measures performed on the same cells, and 
knowing the stoichiometries between the blocks, it is possible to calculate the following fluxes: GTP, 
GLY, LAC, PYR, NAO, PPP, and NPO (Table 1). Additional respiration measurements are required to 
assess H
+ leak flux at different ΔΨm values so that PRL, PHO, and ATC fluxes can be calculated (e.g., 
see [70]). 
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Figure 5. Glucose utilization (A) and lactate production (B) by CGNs in 2-well chambers. 
Neurons were incubated with 350 μl high K
+/serum as detailed in Figure 4. Where 
indicated, 1 μM FCCP was included to increase H
+ leak flux. This modulation was 
propagated through the system via the intermediates to affect glucose uptake and lactate 
production. Data are the mean ± S.E.M. of three independent experiments. Rates are 
expressed in nmol/min x 10
6 cells, as determined from the least-squares regression slopes. 
 
 
Table 1. Reaction block fluxes in healthy neurons. 
Block Flux  Units 
GTP 270  ± 41  pmol glucose/min x 10
6 cells 
GLY 251  ± 13  pmol glucose/min x 10
6 cells 
LAC 406  ± 31  pmol lactate/min x 10
6 cells 
PYR 95  ± 8  pmol pyruvate/min x 10
6 cells 
NAO 95  ± 8  pmol NADH/min x 10
6 cells 
PPP 19  ± 29  pmol glucose/min x 10
6 cells 
NPO 38  ± 57  pmol NADPH/min x 10
6 cells 
PHO nd   
PRL nd   
ATC nd   
Measurement of glucose uptake, lactate production, and respiration rates were used to calculate the 
fluxes using established stoichiometries between the blocks. Data are mean ± S.E.M. of six 
independent experiments. PYR and NAO fluxes are identical because a 1:1 stoichiometry exists for 
pyruvate oxidized and net NADH produced through glycolysis; it is assumed that all of this NADH 
is oxidized by mitochondria. To calculate PHO, PRL, and ATC fluxes, additional experiments are 
necessary to determine the kinetics of PRL to ΔΨm so that the proportion of oxygen utilized for 
ATP synthesis can be assessed. nd: not determined. Int. J. Mol. Sci. 2009, 10                 
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7. Conclusions 
 
Glycolytic and mitochondrial flux changes have been measured in response to trophic factor 
withdrawal from a variety of cell types. Measured changes in the activity of one or more 
glycolytic/mitochondrial proteins have been suggested to account for the flux changes. However, 
metabolic flux is controlled by a number of interactions, all of which should be considered to obtain a 
comprehensive picture of the routes through which an effector induces a flux change. These 
interactions include the responsiveness of the enzymes to the intermediates in the pathway (reflected in 
the elasticity coefficients), and the influence that each enzyme has on the concentrations of the 
intermediates, and thus the flux catalyzed by the other enzymes in the pathway (reflected in the flux 
control coefficients). There are few reports indicating the extent to which a direct kinetic change in a 
particular protein accounts for a pathway flux change. Moreover, the contribution of indirect effects- 
changes in the concentrations of the intermediates within the pathways of interest- have not been 
determined during apoptosis. Identifying kinetic changes brought about directly by an apoptotic 
stimulus, and the importance of this in causing a flux change, would be useful to understanding the 
possible role of metabolism in signaling apoptosis. Such a comprehensive picture can be attained using 
the top-down approach to control analysis. The utility of the approach to understanding how hormones 
alter cellular metabolism has been described, and its direct applicability to understanding the routes 
responsible for an observed flux change during apoptosis is apparent. Measurement of respiration rate 
is central to the determination of metabolic fluxes. This can be difficult when using adherent cells such 
as neurons, but through the use of a new technique such measurements are feasible. 
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